12 July 2016 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) has approved the switch of Galderma's Differin Gel (0.1% adapalene) from prescription to OTC status. Galderma said adapalene was the "first new active ingredient approved to treat acne without a prescription in over 30 years".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.